YIA
ABMD

YHB Investment Advisors’s Abiomed Inc ABMD Stock Holding History

YHB Investment Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,790
Closed -$1.42M – 292
2022
Q3 		$1.42M Sell
5,790
-83
-1% -$22.4K 0.16% 121
2022
Q2 		$1.45M Hold
5,873
– – 0.15% 124
2022
Q1 		$1.95M Sell
5,873
-33
-0.6% -$10.2K 0.17% 118
2021
Q4 		$2.12M Sell
5,906
-4
-0.1% -$1.35K 0.17% 122
2021
Q3 		$1.92M Hold
5,910
– – 0.17% 124
2021
Q2 		$1.84M Hold
5,910
– – 0.16% 129
2021
Q1 		$1.95M Hold
5,910
– – 0.17% 126
2020
Q4 		$1.92M Sell
5,910
-1
-0% -$277 0.18% 116
2020
Q3 		$1.64M Hold
5,911
– – 0.18% 116
2020
Q2 		$1.43M Sell
5,911
-101
-2% -$20.3K 0.21% 89
2020
Q1 		$873K Hold
6,012
– – 0.15% 106
2019
Q4 		$1.03M Sell
6,012
-270
-4% -$50.1K 0.15% 110
2019
Q3 		$1.12M Sell
6,282
-1,136
-15% -$246K 0.17% 105
2019
Q2 		$1.93M Sell
7,418
-560
-7% -$149K 0.31% 85
2019
Q1 		$2.28M Buy
7,978
+20
+0.3% +$6.65K 0.36% 79
2018
Q4 		$2.59M Hold
7,958
– – 0.46% 61
2018
Q3 		$3.58M Sell
7,958
-700
-8% -$276K 0.54% 58
2018
Q2 		$3.54M Sell
8,658
-280
-3% -$101K 0.58% 55
2018
Q1 		$2.6M Sell
8,938
-528
-6% -$134K 0.44% 70
2017
Q4 		$1.77M Sell
9,466
-126
-1% -$23.5K 0.3% 92
2017
Q3 		$1.62M Hold
9,592
– – 0.29% 90
2017
Q2 		$1.38M Hold
9,592
– – 0.24% 94
2017
Q1 		$1.25M Hold
9,592
– – 0.24% 95
2016
Q4 		$1.08M Buy
9,592
+265
+3% +$30.7K 0.23% 99
2016
Q3 		$1.2M Buy
9,327
+160
+2% +$19.2K 0.29% 92
2016
Q2 		$1M Buy
9,167
+767
+9% +$76.3K 0.22% 97
2016
Q1 		$796K Sell
8,400
-491
-6% -$41.4K 0.21% 96
2015
Q4 		$803K Hold
8,891
– – 0.18% 108
2015
Q3 		$825K Sell
8,891
-469
-5% -$41.3K 0.19% 110
2015
Q2 		$615K Sell
9,360
-320
-3% -$21.3K 0.13% 118
2015
Q1 		$693K Sell
9,680
-167
-2% -$9.06K 0.16% 115
2014
Q4 		$375K Sell
9,847
-175
-2% -$5.52K 0.09% 130
2014
Q3 		$249K Hold
10,022
– – 0.06% 141
2014
Q2 		$252K Hold
10,022
– – 0.06% 140
2014
Q1 		$261K Buy
10,022
+136
+1% +$3.76K 0.07% 139
2013
Q4 		$264K Sell
9,886
-815
-8% -$20.1K 0.07% 135
2013
Q3 		$204K Buy
10,701
+526
+5% +$12K 0.06% 138
2013
Q2 		$219K Buy
+10,175
New +$204K 0.07% 137

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

YHB Investment Advisors's ABMD Position: Q4 2022 in Review

YHB Investment Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 5,790 shares — an estimated $1.42M sold.

YHB Investment Advisors first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $3.58M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • YHB Investment Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • YHB Investment Advisors sold 5,790 Abiomed Inc shares in Q4 2022, an estimated $1.42M.
  • YHB Investment Advisors first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
  • YHB Investment Advisors's Abiomed Inc position peaked at $3.58M in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on YHB Investment Advisors's 13F filing for Q4 2022, filed 12 Jan 2023.